Neurorehabilitation Ecosystem for Sustained Therapy (NEST): A Feasibility Study
Launched by HOSPITAL UNIVERSITARI VALL D'HEBRON RESEARCH INSTITUTE · Jan 12, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Neurorehabilitation Ecosystem for Sustained Therapy (NEST) study is exploring a new way to help stroke patients recover at home. Stroke affects millions of people each year, and many need help with physical and mental rehabilitation. NEST focuses on creating a personalized rehabilitation program using advanced technology, including video games and virtual reality. This program aims to improve patients' arm movement and overall quality of life by providing exercises that they can do at home with the help of a wearable device and a smartphone app.
To participate in this study, individuals must be adults aged 18 to 80 who have experienced their first stroke at least three months prior and have mild to moderate difficulty using their arm. Participants should also be comfortable using smartphones. The trial will assess how easy it is to use the NEST system, how well it helps improve arm movement, and gather feedback from users to make the program even better. If you or someone you know meets these criteria, this could be an exciting opportunity to be part of a study that aims to enhance stroke recovery at home.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients presenting a first-ever ischemic or hemorrhagic stroke at least three months prior to study recruitment, confirmed by brain CT or MRI;
- • 2. Mild to moderate motor impairment of the upper extremity (MRC ≥ 2)
- • 3. Age = 18 - 80 years old;
- • 4. Able to sit in a regular chair or wheelchair;
- • 5. Experience with smartphone technology
- Exclusion Criteria:
- • 1. The presence of a condition or abnormality that could compromise the patient's safety or data quality;
- • 2. Severe cognitive impairments that prevent the execution of the experiment (MoCA \< 19). This cut-off point is based on a pilot study (Maier, M. et al., 2019).
- • 3. Arteriovenous malformation or other brain lesions not related to stroke;
- • 4. Previous history of upper limb motor impairment
- • 5. Sensory aphasia;
- • 6. Associated impairments: spasticity of the upper limb (Modified Ashworth scale≥ 3), apraxia, major pain, or other impairments that would interfere with the correct execution of the experiment;
- • 7. The NEST system cannot be used independently according to the therapist's observations and there is no available support from a caregiver to help use the system;
- • 8. No experience with smartphone technology.
About Hospital Universitari Vall D'hebron Research Institute
The Hospital Universitari Vall d'Hebron Research Institute (VHIR) is a leading biomedical research center affiliated with Vall d'Hebron University Hospital in Barcelona, Spain. Committed to advancing healthcare through innovative research, VHIR focuses on translating scientific discoveries into clinical applications, enhancing patient care and outcomes. The institute fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, emphasizing excellence in translational medicine, clinical trials, and public health initiatives. With a strong emphasis on ethical standards and patient safety, VHIR is dedicated to contributing to the global body of knowledge in various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nijmegen, , Netherlands
Ancona, , Italy
Patients applied
Trial Officials
Susana Rodriguez, MD
Principal Investigator
Hospital Vall d'Hebron
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported